Diagnostic revolution
Breakthrough
Prediction Software Platform
The new generation of clinical decision support software.
Personalize and optimize your therapy and care decisions for each individual patient.
NeoPrediX B.1
NeoPrediX B.1
Neonatal Clinical Decision Support Platform
Experience how to predict critical disease progression and risks immediately!
The new generation of clinical decision support software.
Personalize and optimize your therapy and care decisions for each individual patient.
Pregnancies
per year
Births
per year
Premature Babies
per year
A WORLD INNOVATION
NeoPrediX B.1:
Predicting Newborn Jaundice
NeoPrediX B.1 is an intelligent algorithm implemented into our newly launched software platform. This algorithm is based on data of thousands of newborns & developed with the help of artifical intelligence. Using only a few individual data points our software is able to predict bilirubin progression for the next 48 hours.
Save valuable time now!
Bilirubin can cause neonatal jaundice and kernicterus. The software platform can be used to predict further progression of bilirubin for at least 2 days (48 hours).
Your benefits
- standardized care
- improved workflows
- personalized care
- increased patient satisfaction
- cost savings
- easy to use
Neonatology
What if you knew earlier?
The first weeks after birth in particular are crucial for the newborn’s longterm health. Your clinical decision is impacting the newborn’s future.
Jaundice, bacterial infections, cardiovascular threats: Imagine how helpful it could be to know about the risk of dangerous diseases, right after birth – or even before? Early decisions enable new opportunities: Personalized diagnostics and treatment for more efficiency in your clinic.
Our vision
We enhance and personalize healthcare in early life.
Our mission
We transform medical data into intelligent predictions to support clinical decisions.
Career Opportunities
Designing the future of medicine. With you.
We are a young, innovative company in the medical technology software field. The company is a spin-off from the University of Basel. A diverse, highly motivated team driven by desire for achievement and passion for children and their families provides an ideal work environment. A high degree of independence and self-organization together with short decision-making paths makes us agile and efficient. We are developing new, individual treatment solutions to enhance perinatal and neonatal care.
Your input is appreciated.
Feel free to send an unsolicited application. We are always looking for experts for our future projects.
Technical Product Manager (all genders)
The team of experts
Experience for progress -
a highly qualified leadership team
Thorsten Waloschek
CEO
Thorsten Waloschek MBA is a senior industry executive who is passionate about bringing new and innovative products to market that have a positive impact on patients, their families and clinicians.
Marc Pfister
CSO
Prof. Marc Pfister MD FCP is a clinician, researcher, innovator and entrepreneur who is passionate about intelligent digital health solutions that improve lives of children and their families.
Jörg Schmidt
CFO
Jörg Schmidt is a senior financial executive in Life Sciences and the MedTech industry who is passionate about leading financial business projects to bring innovative companies & their products to market successfully.
Sven Wellmann
CMO
Prof. Sven Wellmann MD MBA is a leading researcher, pediatrician and neonatalogist who is passionate about enhancing and personalizing treatment early in life to improve clinical outcome.
Contact our team
Discover prediction for your clinic
You would like to learn more about our innovative software platform and our company? Please feel free to contact us at any time for further questions and requests.
Contact our innovative team
This email address is being protected from spambots. You need JavaScript enabled to view it.
